Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 26, 2025, 11:21 AM EDT
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $120.66 thousand as of August 26, 2025. Its market cap has decreased by -73.33% in one year.
Market Cap
120.66K
Enterprise Value
n/a
Revenue
255.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 120.66K, an increase of 52.93%. That is a compound annual growth rate of 3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 120.66K | -44.54% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | 493.17K | -74.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |